Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2014 | 10-2013 | 10-2012 | 10-2011 | 10-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,525 | -19,987 | -12,070 | -8,116 | -10,812 |
| Depreciation Amortization | 203 | 283 | 1,795 | 643 | 689 |
| Accounts receivable | N/A | N/A | N/A | 245 | -245 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 389 |
| Other Working Capital | -4,548 | -277 | 5,875 | 2,338 | 254 |
| Other Operating Activity | 4,785 | 11,267 | -168 | -4,053 | 3,301 |
| Operating Cash Flow | $-16,085 | $-8,714 | $-4,568 | $-8,943 | $-6,424 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -22 | -92 | N/A | -12 |
| Purchase Sale Intangibles | -415 | -274 | -305 | -296 | -855 |
| Other Investing Activity | -415 | -274 | -305 | -296 | -855 |
| Investing Cash Flow | $-440 | $-296 | $-397 | $-296 | $-867 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 11 | 325 | 295 | 1,255 |
| Debt Issued | N/A | 2,969 | 3,283 | 8,351 | 80 |
| Debt Repayment | N/A | -691 | -53 | -170 | N/A |
| Common Stock Issued | 14,581 | 27,439 | N/A | N/A | N/A |
| Other Financing Activity | -1,002 | -166 | 315 | 1,751 | 5,405 |
| Financing Cash Flow | $13,579 | $29,562 | $3,869 | $10,227 | $6,740 |
| Beginning Cash Position | 20,552 | 0 | 1,097 | 108 | 660 |
| End Cash Position | 17,607 | 20,552 | 0 | 1,097 | 108 |
| Net Cash Flow | $-2,945 | $20,552 | $-1,096 | $988 | $-551 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,085 | -8,714 | -4,568 | -8,943 | -6,424 |
| Capital Expenditure | -25 | -25 | -92 | N/A | -12 |
| Free Cash Flow | -16,109 | -8,739 | -4,660 | -8,943 | -6,436 |